Ian, who qualified from Melbourne University in 2004 after completing a neuroscience degree at Edinburgh University, first joined Rowe as a general practitioner in 2007.
He said: “Personally this achievement is incredibly rewarding, but I also see it as an important step for veterinary neurology in the UK.
"It’s a fast-growing field with an increasing need for expert treatment and care so it’s exciting to see it recognised at this level.”
https://www.rowereferrals.co.uk
The introduction of the new Level 3 Diploma in Veterinary Nursing has seen an increase in numbers of both students and training practices, according to statistics released today by the RCVS.
Since January, the RCVS has approved over 30 more Training and Auxiliary Training Practices, bringing to a total of 1,559 the number of practices approved for veterinary nurse (VN) training. Scope for practices to train student VNs is increased through the emphasis on Auxiliary Training Practices (aTPs), an option for practices without the full facilities or caseload needed for student training. Students at aTPs complete their in-practice training at other aTPs or full Training Practices. Of the 31 new practices approved since January for student training, eight are aTPs.
The number of VN students enrolling with the RCVS has also increased, with almost double the number enrolling in January 2011, compared with January 2010. There were a total of 1,168 student enrolments in the 12 months from 1 February 2010, compared with 1,121 enrolments in the same period from 1 February 2009.
Libby Earle, Head of the RCVS Veterinary Nursing Department said: "The Level 3 Diploma has been in place for little more than six months, yet VN student numbers are already up. This bodes well for the supply of qualified, competent registered veterinary nurses demanded by veterinary practices, and for those keen to enter the veterinary nursing profession."
The qualification was introduced when the government abolished the National Vocational Qualification (NVQ) system last summer, forcing a change in the vocational qualifications for VNs. The resulting Level 3 Diploma is designed to better meet the needs of practices, colleges, and students themselves.
Mars Veterinary is launching the Wisdom Panel Insights mixed breed dog DNA test at the Kennel Club's Discover Dogs event this weekend.
According to the company, more than 2 million dogs in the UK are mixed breed, and it is likely that many owners are unsure of their pet's parentage.
Now, with the swipe of a cheek swab, Wisdom Panel Insights can determine the ancestry of a mixed breed dog by testing for more than 185 breeds, which Mars Veterinary says is the largest database of any canine DNA test on the market. Within three weeks, dog owners are emailed an official Ancestry Report that reveals the dog's genetic background. This, it is claimed, will help owners provide better training, nutrition and exercise for their pet, and will also alert them to any disease predisposition their dog may have.
The test will be on sale for the first time at Discover Dogs at Earl's Court, and from the website: www.wisdompanel.co.uk. It costs £59.99 inc. vat, discounted for Kennel Club registered dogs.
Caroline Kisko, Secretary of the Kennel Club, said: "A dog's ancestry can influence him in surprising ways. Obvious and not-so-obvious physical traits plus behaviours like digging, herding and barking all come from the various breeds in a dog's family tree. Once an owner understands a dog's natural tendencies, it makes it possible to create a tailored training, exercise and nutrition program to fit his one-of-a-kind needs. This is one of many innovative products that dog owners and lovers will find at Discover Dogs this weekend."
Novartis Animal Health has published a product usage chart aimed at vets and SQPs that gives guidance on the use of ectoparasites through the seasons.
The chart covers the use of blowfly preventatives CLiK and CLiKZiN, and the blowfly strike treatment Crovect, which also covers ticks, biting lice, headfly and fly maggots.
There is advice on the treatment of pre- and post-shearing ewes, and early season and main season lambs, plus recommendations for end of season treatments.
Helen Langham, Brand Manager at Novartis Animal Health, said: "The chart is designed to provide an overview of the ectoparasite challenges faced by sheep and lambs through the year, and explain which products should be applied and when.
"SQPs can download the chart and a full range of information about ectoparasites from the Novartis Farm Animal Health website."
The chart can be downloaded from www.farmanimalhealth.co.uk
Intervet reports that a clinical trial of 489 cows on dairy farms in the south west last spring and summer has demonstrated some excellent efficacy levels for treating and preventing intramammary infections in the dry period and early lactation.
The trial compared Cephaguard® DC and a 600mg cloxacillin dry cow tube (OEDC) on its own, and in combination with a teat sealant. Cephaguard DC demonstrated superior efficacy in terms of infection prevention during and after the dry period relative to cloxacillin alone, and was statistically equal to the combination treatment group.
Indeed, cows treated with cefquinome (Cephaguard DC) were around half as likely to develop mastitis in the first 100 days post calving than those treated with cloxacillin alone.
The trial also demonstrated excellent efficacy levels against existing Strep. uberis infections when compared with cloxacillin (see table).
DRY PERIOD CURE RATES (%) OF KEY MASTITIS PATHOGENS
Cephaguard DC
Cloxacillin (600mg)
Strep. uberis
100
75
E. coli
92.31
Coagulase +ive Staphs
66.67
S. dysgalactiae
Intervet’s large animal veterinary adviser Rosemary Booth said: "With Intervet’s Cephaguard bacteriology scheme showing that Strep. uberis is responsible for 18% of high cell counts and 23% of clinical cases, the dry period offers a fantastic time to treat this persistent pathogen."
She added: "Several weeks of exposure to an effective dry cow antibiotic provides a particularly good opportunity to kill the cow-adapted strain of Strep. uberis. It lives quite happily in the udder and is tougher and harder to kill than the environmental strain."
The cloxacillin-treated group was significantly more likely to develop clinical mastitis compared to the cefquinome-treated group, as is shown in the table below:
First quarter clinical mastitis cases up to 100 days post calving in quarters not sampled in transition
OEDC
Total major pathogens
12
21
Total with enterobacterial involvement
6
Total cases
26
41
According to Intervet, the study results suggest that reviewing dry cow therapy this summer, and moving to a cefquinome-based treatment may help reduce the incidence of mastitis. Further information on the study will be presented at the Large Herd Seminar on 30 June 2008 and is available from Intervet.
Boehringer Ingelheim has announced that its 'Talk About Laminitis' campaign will run from Mid March until the end of June.
Last year, the initiative saw over 9000 horses and ponies tested for PPID through its free ACTH test scheme. This year, to build on this success and support the testing of even more animals, the company has announced a high impact, co-ordinated campaign to drive awareness that up to 90% of laminitis cases may have an underlying endocrine cause1,2.
Once again, Boehringer is urging veterinary surgeons to carry out free ACTH blood tests on laminitic or foot-sore horses as part of the campaign, which is backed by Redwings, The British Horse Society and World Horse Welfare.
Professor Andy Durham from the Liphook Equine Hospital, where the ACTH tests are performed, said: "We are learning so much from these tests. For example, we are now recognising PPID routinely in laminitic horses and ponies as young as 10 years old, and in the spring when we might expect to see more EMS cases, where veterinary surgeons have also tested for PPID we are seeing both abnormally elevated ACTH and insulin. Unless the PPID is addressed, horses will continue to be at risk of painful recurrent laminitic episodes which is a significant welfare issue to the horse and extremely frustrating for owners."
To participate in the scheme, veterinary surgeons and horse owners can download ACTH blood test vouchers from www.talkaboutlaminitis.co.uk. Attach the voucher to the ACTH sample submission form and the ACTH laboratory fees will not be charged.
Lee Hackett from The British Horse Society said: "Without the 'Talk About Laminitis' initiative and the support of Boehringer Ingelheim, literally thousands of horses may not be receiving the appropriate treatment and management for their laminitis to help prevent recurrence. We hope as many veterinary surgeons as possible get involved this year to continue this welfare success."
To ensure that horse owners are fully aware of the initiative, a PR and advertising campaign in the equine consumer media will start in March. The ad campaign includes an infomercial on Horse & Country TV (SKY Channel 280), with viewer numbers in excess of 450,000 per month.
There will also be a live online broadcast for horse owners on endocrinopathic laminitis presented by David Rendle BVSc MVM CertEM(IntMed) DipECEIM MRCVS, from the Liphook Equine Hospital in Hampshire. The one-hour webinar, which takes place at 8.00pm on Wednesday 10 April, will educate horse owners on how the veterinary profession's understanding of this debilitating and devastating disease has been completely revolutionised over the past five years. It will be followed by an interactive Q&A session when viewers will be able to pose questions for David to answer.
David said: "As our knowledge of the two hormonal diseases responsible for the majority of cases of laminitis improves, veterinary surgeons can offer their clients more comprehensive advice on treatment options to prevent laminitis. For many owners who have struggled with this condition, this is an absolute revelation and has enormous welfare benefits".
Horse owners can register to view the online programme by visiting www.talkaboutlaminitis.co.uk.
To ensure that veterinary surgeons are versed in the most up to date research available, Boehringer Ingelheim will also be hosting a webinar for veterinary professionals at 8.00pm on Wednesday 13th March, presented by Professor Andy Durham BSc BVSc CertEP DEIM DipECEIM MRCVS. The online seminar, 'The laminitis revolution.... An update on our understanding of endocrinopathic causes of laminitis', will entitle the viewer to a downloadable certificate for one hour of CPD. To register, visit www.bi-academy.co.uk. Places are limited, so register early to avoid disappointment. The webinar will also be available to view after the event on demand.
For further information on how you can promote 'Talk About Laminitis' in your practice contact your Boehringer Ingelheim Territory Manager or call 01344 746959
References
1. Karikoski et al. (2011). The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital. Domestic Animal Endocrinology 41 111-117
2. Donaldson et al. (2004). Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis. J Am Vet Med Assoc;224:1123-1127.
The Animal Health Trust has repeated its call for veterinary surgeons to take part in its survey study on breed differences in clinical features of canine hyperadrenocorticism.
40 veterinary surgeons have so far taken part in the survey, and preliminary results show that some breeds tend to present with fewer clinical signs than others, which fits with the study's initial hypothesis.
In addition, researchers say that the frequency of most of the clinical signs in dogs affected by hyperadrenocorticism, including polydipsia, polyuria, polyphagia, abdominal distention, alopecia, panting, comedones and muscle weakness, seem to be lower than previously reported in earlier studies published decades ago.
The AHT says it hopes the results of this study will help veterinary surgeons in the diagnosis of canine hyperadrenocorticism. However, in order to progress the study and draw firm conclusions, more responses from veterinary surgeons are needed.
Michael Bennaim, veterinary surgeon at the AHT, said: "We need members of the veterinary profession to help us increase knowledge of this disease and to promote this study to their colleagues. The online questionnaire takes around 10 minutes to complete and all the information that is collected will be processed anonymously."
The AHT requests that the online questionnaire is completed for each case diagnosed with spontaneous hyperadrenocorticism . The questionnaire can be found at http://bit.ly/aht-cushing
Participants can request to be notified of the results of this study when available. Each questionnaire submitted has a chance to win a £100 Amazon voucher.
If you have any questions about the study, contact michael.bennaim@aht.org.uk.
The International Veterinary Epilepsy Task Force (IVETF), a group of 26 veterinary practitioner, neuropharmacology, neuropathology and neurology experts led by Holger Volk, Professor of Veterinary Neurology and Neurosurgery at the RVC, has issued new guidelines for treating and caring for dogs with epilepsy.
The guidelines have been adopted by the American College of Veterinary Internal Medicine (ACVIM) and published in the form of a ‘consensus statement’ in the Journal of Veterinary Internal Medicine (JVIM).
Professor Volk, who co-chaired the consensus statement process, said: "I was honoured to have been asked to co-chair such an important forum in American veterinary practice. This will be another landmark paper to help improve the care vets deliver for the patients with epilepsy, both in America and beyond.
"Epilepsy is one of the most common neurological diseases encountered by veterinary surgeons and practitioners around the world. The prevalence of the condition means there have been numerous research studies carried out over the years. But, despite such frequent research, there has been a lack of consistency when it comes to diagnosis and treatment.
"This lack of cohesion and collaboration made it difficult for owners and veterinary professionals to communicate effectively on the issue of pet epilepsy. This has led to the global veterinary community changing its approach and, in recent years, working more closely together."
Professor Volk says the aim of these latest guidelines is to provide joined up and collaborative thinking, teaching and learning on various different aspects of the condition that specifically affect America. These include the development of treatment strategies and any potential issues with chronic anti-epileptic drug treatment.
The ACVIM guidelines follow on from seven in-depth consensus statements produced by the IVETF and published open access in BMC Veterinary Research last year, outlining recommendations and classifications on all aspects of canine epilepsy. It was the first time this many veterinary neurology clinicians and neuroscientists formally agreed on the key aspects of the condition.
Professor Volk, who is also the Clinical Director of the RVC’s Small Animal Referral Hospital, added: "There is a real exciting buzz around canine and feline Epilepsy currently. Finally getting to global consensus from the international veterinary community will accelerate research and lead to improved patient care and quality of life for owners and patients alike."
The poster can be downloaded free of charge from NOAH’s Pet Health Info website and a limited number are available from NOAH free of charge on a first-come, first-served basis.
Featuring pet photos from NOAH’s 'Happy healthy pets' project gallery, the planner contains independent seasonal expert tips and advice for pets: from exercise, diet and healthcare to keeping them safe and comfortable in different weather conditions.
Over the coming months, the campaign will continue to roll out tips and expert advice from NOAH and partners, tailored web content, as well as press and social media activity.
The poster is part of ’I Heart My Pet’ campaign, now in its third year, which includes the Happy, Healthy Pets Project – an interactive online gallery, where pet owners have already uploaded more than 2000 images of happy, healthy pets.
NOAH Chief Executive, Dawn Howard said: "We are thrilled that these three great animal welfare charities have joined forces with NOAH to help extend the reach of our collective networks on this project, with the ultimate objective of improving the health of the UK’s pets.
"PDSA’s sterling work through its PAW Report, highlighting areas where we need to focus to improve pet welfare made them an obvious choice and we are delighted to be working with them on this. Cats Protection helps thousands of cats every year and provides invaluable information on cat care. We hope that by working together we’ll be able to assist them in helping many more.
RWAF’s work on educating owners about the responsibility involved in taking on rabbits as pets, through campaigns such as Rabbit Awareness Week, is of vital importance and we look forward to working closely with them to spread the word even further."
The Dogs Trust has officially launched the Free Microchipping Through Vets Campaign through which all owners can get their dog microchipped free of charge through participating veterinary practices.
Microchipping becomes compulsory for all dogs in England in April 2016 and Wales in March 2015, and with 20% of dogs in the UK still unchipped, the charity says it thinks demand for the procedure is likely to be significant over the coming year.
1500 practices have already joined the year-long campaign, as part of which they will be given free microchips in exchange for implanting them at no cost to the owner. The charity says it hopes that up to 75% of the UK's 3075 practices will have joined the campaign within the next few weeks.
Clarissa Baldwin, Chief Executive of Dogs Trust, said: "We are delighted about the proposed new legislation and see it as the start of a very positive movement. From April 2016 in England and March 2015 in Wales it will be compulsory for each and every dog to be microchipped on first change of hands which represents a significant step forward for dog welfare and responsible dog ownership. To show its support for the implementation of this legislation, Dogs Trust is teaming up with vets to make sure that all dog owners can have the procedure done for free. We'd like to say a huge thank you to the vet practices already supporting the campaign and urge others to come on board. An essential element to the success of microchipping is for dog owners to take responsibility for updating their details with the database should their circumstances change.
"Last year 111,986 stray and abandoned dogs were picked up by Local Authorities across the UK, with only 40% reunited with their owners. This initiative will help to reduce that number dramatically."
To join the campaign vet practices should contact Dogs Trust at campaigns@dogstrust.org.uk
Now, when you advertise a job on VetSurgeon.org, the system can send a message to all your employees (and any contacts in the profession) asking them to pass it on if they know anyone suitable, and to share the advertisement on their other social networks, such as Facebook.
As a further option, practices can also now offer a cash reward for a successful introduction leading to the post being filled. In that case, the message sent to employees and contacts lets them know that there’s a reward for their help.
VetSurgeon.org Editor Arlo Guthrie said: "Since we relaunched VetSurgeon Jobs, I’ve noticed a correlation between the number of times that job advertisements are shared by email or on Facebook, and the success that practices have in filling the vacancy.
"Of course, there is nothing to stop you emailing staff and contacts yourself, or offering a reward. But I suspect many don’t, and my hope is that this new feature will really help focus the mind, streamline the process and ultimately help you find the person who'll fit in with your team."
"Share & Reward is another feature exclusively available on VetSurgeon Jobs, alongside the VetSurgeon Locums Map and Find Our Jobs on VetSurgeon (a badge for your website that links to just your jobs).
"There's more on the way!"
Advance25 Courses provide 25 hours of CPD in important areas of small animal practice, including Small Animal Medicine Cases Challenges, Emergency Medicine, Abdominal Ultrasound and Thoracic and Abdominal Radiology.
Advance25 courses run for a 6 week period, with tutor support. Recorded and live sessions are combined with discussion of multiple cases. Course materials are then accessible for 12 months.
Susie Coughlan, Managing Director of CPD Solutions said: "We appreciate that there is a high demand for quality online options at the moment, with many vets limited to online CPD.
"With the new Advance25 courses we’ve added more tutor support and ongoing interaction for those who are looking for a more immersive experience providing extended CPD hours. We’re really excited about these courses, which are launching now and running in the autumn. They should help vets make a real difference in their practices; they’re fully flexible and will fit with many people’s family and work commitments.’
For more information and to enter a prize draw to win a free Advance25 course, visit: https://www.cpd-solutions.com/advance25
The webinars will be delivered by board-certified equine diagnostic imaging specialists.
The first will cover equine cervical spinal radiographic interpretation presented by Erin Porter, DVM, DACVR, DACVR-EDI. Learning objectives include:
The second webinar will be on 7th February 2024, 1:00-2:00pm, when Marianna Biggi, DVM, PhD, FHEA, DipECVDI, MRCVS, will review a systemic approach to interpreting foot radiographs and the clinical significance of radiographic diagnoses.
In the final webinar on February 26th at 1:00pm, Lucy Meehan-Howard, BVSc, MSc, CertAVP(VDI), DipECVDI, MRCVS, will cover typical injuries to the fetlock in different kinds of horses and the optimal imaging strategy for each type of injury.
Information about all webinars is available here: welcome.vet-ct.com/equine-webinar-series. To learn more about VetCT, plus additional educational content and teleradiology services, visit https://uk.vet-ct.com/.
welcome.vet-ct.com/equine-webinar-series
From the beginning of October this year, the electronic recording of pig movements will be written into legislation.
Following a recent consultation, Defra intends to amend the existing Pigs, Records, Identification and Movements Order (PRIMO) 2007 to reflect the requirement of pre-notification of movements.
Dorothea Schiemann of BPEX said: "There will be a transitional period of six months for the phasing out of the paper-based AML2 forms, planned to start from 1 October 2011. This will give producers and businesses the opportunity to adjust to the change in process.
"From April 2012 the AML2 paper forms will cease to be a valid method of reporting movements. Pig movements will either have to be reported using the free eAML2 online service or the free eAML2 bureau service and there will also be third party agents such as marketing groups or the British Pig Association."
Following extensive trialling, the eAML2 system for farm to slaughter movements was launched in April 2011 across England and Wales. The functions for movements from farm to farm, market, collection centre and show, and for import and export, will be introduced in due course.
Benefits include the fact that the industry will have a realistic herd register providing accurate and timely information. This will enable better communication and control in the event of disease outbreak. There will be no need to fill in the same information again and again as the eAML2 service will pre-populate the basic information automatically. Also, when pigs are sent to slaughter, the system combines the movement licence and Food Chain Information (FCI) form in one, which will save producers time.
For more information and to register to use the system go to: http://www.eaml2.org.uk/
Kruuse has launched Krutex Polyisoprene Surgical Gloves, which are both powder and latex-free to minimise the risk of glove-related allergy to latex protein.
The gloves are made from synthetic polyisoprene, which has a molecular structure similar to natural rubber latex. This, says the company, means the gloves have a fit, sensitivity and comfort equal to natural rubber latex. The company says they are also designed to provide increased fingertip sensitivity.
Andrew Groom Managing Director, Kruuse UK Ltd said: "After feedback from our customers showed an increasing concern regarding latex allergies amongst clinicians, we were encouraged to develop this addition to our well established range of gloves."
Krutech latex free gloves join the existing Krutech range which includes; Vet Gel surgeons' gloves, Krutech latex surgical gloves, Krutech latex, vinyl and nitrile examination gloves and the widely used arm length gloves range. The new range is supplied in boxes of 25 sterile, single packed pairs and are available in half sizes from 6.0 to 9.0.
Alstoe Ltd has launched Tempora, a chewable, flavoured, spironolactone tablet for dogs, indicated for the treatment of congestive heart failure (CHF) arising from mitral valve disease.
Alstoe says Tempora's flavouring technology, tablet shape and two and four way break tablets facilitate ease of use and should improve compliance. The company also highlights the affordability of the new product, which can be used alone or in conjunction with standard therapies.
According to Alstoe, it is estimated that in 75% of dogs with CHF, degenerative mitral valve disease is the underlying cause. The company says spironolactone shows clear benefits in treating mxyomatous mitral valve disease (MMVD) in dogs: acting as an aldosterone receptor antagonist it counteracts the negative consequences of aldosterone production such as myocardial fibrosis and myocardial and vascular remodelling.
To support the new product, Alstoe has designed a Sleep Respiratory Rate (SRR) chart to assist veterinary professionals with ongoing monitoring of their canine patients condition and response to treatment. The chart is available as a printable download or in pads. The company is also offering lunchtime practice seminars.
Tempora is available as 10mg, 50mg and 100mg tablets.
For further information, contact Alstoe Animal Health on 01347 878606, or via e-mail: adelaideellerington@alstoe.co.uk, or visit www.alstoe.co.uk
Reasonable adjustments can include changing working arrangements and providing equipment, services and support.
The campaign will address common myths and misconceptions surrounding reasonable adjustments and highlight the legal obligations of leaders and managers around implementation.
The campaign, which will run until the end of July, is being launched after an RCVS/British Veterinary Chronic Illness Support (BCVIS) survey concluded there is a need to increase awareness about reasonable adjustments, promote wider discussion and equip organisations with the information they need to implement them.
The research also indicated that improved knowledge of legislation is needed, with communication also being raised as an important issue, so that individuals feel empowered to ask for the support they need.
MMI Lead, Rapinder Newton, said: “Our ‘Let’s talk adjustments’ campaign will support people to have these important conversations by sharing information, educational resources and guidance on good practice.
"It will also provide examples of different types of adjustments, including examples that are specific to the veterinary context.
“We know that physical and mental health are deeply interconnected.
"Reasonable adjustments can support both physical and mental health but also helps to safeguard mental health through allowing individuals with disabilities to thrive.
“We will be keeping people updated on the campaign, which has its own dedicated section on the RCVS website, via the RCVS social media channels, as well as providing information in RCVS newsletters, so do keep an eye out for this over the coming months.”
https://www.rcvs.org.uk/lifelong-learning/leadership-diversity-and-inclusion/reasonable-adjustments-campaign/
Photo courtesy: https://depositphotos.com
Intervet/Schering-Plough Animal Health has announced that it is to sponsor the Equine Business Management Strategies (EBMS) program, a targeted business education program developed for equine veterinary surgeons and practice professionals.
According the company, this 5-day course has proven very successful in the United States. It had its European kick-off in Amsterdam on August 22, 2010, where a group of almost forty equine practitioners from North America and Europe gathered to discuss and learn how to apply business principles in their day-to-day work. The program was chaired by Dr. Joop Loomans, an equine veterinary surgeon responsible for equine business management education at the Department of Equine Sciences of the Veterinary Faculty of Utrecht University (The Netherlands).
Course participants worked with international specialists on strategic planning, benchmarking, branding and change management to create strategic plans to implement at their practices, and to share their knowledge, experience and ideas.
Intervet/Schering Plough says the launch of Equine Business Management Strategies program exceeded expectations of participants, sponsor and organizers. The chance to look at the day-to-day practice from a different angle and to learn about things like benchmarking exercises, revenue analysis and branding was highly appreciated. Participant Jeremy Mantell from Liphook Equine Hospital in the UK said: "The EBMS has given me a clearer understanding of what I need to change and develop in my practice."
Dr. Roberto Ragni-Alunni, Global Technical Manager Equine at Intervet/Schering-Plough Animal Health said: "We believe that running an equine practice is not based solely on technical and scientific skills but also on effective practice management. That is why our company has decided to support this initiative. Intervet/Schering-Plough Animal Health also continues its custom of providing not only innovating products, but also new, value-added services to strengthen its bond with veterinarians."
National Veterinary Services has announced that from 14th January, veterinary practices will be able to place their daily orders up to 8pm, 7 days a week.
The veterinary wholesaler will also be providing a telephone ordering service on Saturday mornings from 9am until 12pm.
Martin Riley, NVS Managing Director said: "We are always keen to understand practice needs and to deliver on their requests. This is a significant change for the industry and with the introduction of more new tools and services later in the year we believe NVS will make a great difference to our customers."
For further information please contact 01782 770319.
In the study titled “Evaluation of urethral orifice cross-section dimensions following perineal urethrostomy in male cats”, 24 male cats with lower urinary tract disease underwent the procedure. The urethral orifice cross-section was estimated by the largest urinary catheter that could be easily inserted through the stoma at three time points: preoperatively, intra-operatively and 12 days postoperatively. Cases of obstruction recurrence and stricture were documented within the six month follow up period.
Uri Segal, corresponding author for the paper, said: “The intraoperative stoma ranged from 1 to 10 (median 10) Fr and the 12-day postoperative stoma ranged from 4 to 10 (median 8) Fr. There was significant reduction of stoma size 12 days postoperatively, compared to the measurements taken intraoperatively.
"Postsurgical stricture formation and re-obstruction was documented in five of 24 (21%) of cats. Obstruction recurrence is probable if the intra-operative stoma size is 8 Fr or less. Furthermore, if the stoma size is 6 Fr or less, re-obstruction is almost certain (all of these cases in the study were re-obstructions). Conversely, an intra-operative stoma of more than 8Fr had a low risk of recurrence.”
Nicola Di Girolamo, editor of JSAP said: “These findings may function as a guiding rule for surgeons performing perineal urethrostomy, by providing an intraoperative measure of how likely re-obstruction and stricture formation is to occur. It should be remembered, however, that the functional urethral stoma cross-section may vary during the urination cycle and the measurements in this study are likely to only represent a fraction of the functional urethral cross-section size.”
The full article can be found in the August issue of the Journal of Small Animal Practice. It can also be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13148
Reference
The role was created last November when the Animal & Plant Health Agency (APHA) started allowing para-professional staff to support vets in carrying out TB testing in England.
UK Farmcare says there are now 49 fully authorised ATTs in England with another 21 TB testing under veterinary supervision and three undergoing the theory part of the training.
To become an ATT, applicants must be at least 18 years old, hold a valid UK driving licence and passport, possess a clean criminal record and then be approved by the APHA. Applicants also need at least three graded GCSEs or equivalent in English, Maths and a science or food production subject and at least six months cattle handling experience.
https://ukfarmcare.com/an-introduction-to-the-att-role.
Royal Canin has announced that it has established a team of three specialist advisors to work directly with veterinary practices to help develop and improve their weight management clinics, client retention and product sales.
The Pet Weight Care Team will also provide practical training to all practice staff on how to recognise weight problems, communicate sensitively with pet owners and treat the problem effectively.
The first advisor to join the team is Shelley Holden VN (pictured right), who has 10 years' experience as the nurse for the Royal Canin Weight Management Referral Clinic at The University of Liverpool. Shelley has spent time running successful nursing clinics in general practice and lecturing internationally on the topic of obesity. She said: "I have spent many years dedicating my time caring for overweight pets, and the number of cases we see is continuing to rise. It's really important that as obesity specialists we can offer hands-on support to practices to assist them with helping to decrease the number of overweight pets they see.
"Our aim will be to offer specialist training through a number of sessions to practices who wish to improve their weight management clinics. We'll spend time with all members of staff helping them to feel more confident when dealing with owners who have overweight pets. The training will include all aspects of weight management including how to approach owners, Body Condition Scoring and the 30 minute consult. Staff will also be trained on how to support owners throughout the weight loss program and during the maintenance phase."
Royal Canin says the training will also cover the prevention of obesity in pets, how to advise owners on the appropriate diets post neutering and how to manage the animal's weight and calorie intake throughout their lives. The Pet Weight Care Team will be encouraging practices to carry out weight management assessments alongside medical examinations to ensure that potential weight problems are dealt with quickly.
The company says that practices that receive training will be followed up with on a regular basis to provide further support and training as needed.
For more information, contact your Royal Canin Veterinary Business Manager.
Virbac has announced the launch of Speed Trio, an in-house diagnostic test to enable the detection of FeLV (Feline Leukaemia Virus) antigens; anti-FIV (Feline Immunodeficiency Virus) and anti-FCoV (Feline Coronavirus) antibodies in 15 minutes.
The company says Speed Trio is designed to facilitate the diagnosis of immunosuppressive diseases, such as FIP (feline infectious peritonitis); when a cat tests positive for Feline Coronavirus and either FeLV or FIV it is at increased risk of developing FIP¹ and serological testing for all three diseases is the logical step.
Virbac says it has also enhanced the entire Speed range to further improve the readability of the tests and the brightness of the test bands.
Product Manager Madeline Haynes said: "The Speed range, which has been proven in practice for more than 20 years, offers a comprehensive suite of in-house diagnostic tests, which are easy to perform and highly cost-effective to use in practice.
"Speed Trio is not only a unique test combination that helps to facilitate diagnosis of immunosuppressive diseases but also boosts client satisfaction and can support practice profitability."
The plan covers mortgage or rent payments of up to £2000 per month for up to a year if you are unable to work because of illness or injury.
In addition, policyholders, their partners and children under the age of 18 are given access to a 24/7 GP service, available via video or phone consultations.
VetYou says there no health or financial questionnaires involved, and whilst permanent conditions and those present within the last two years are not covered, Home Protection will start to cover pre-existing conditions when you have been symptom, medication and treatment free for two years.
There are 12 types of higher risk sports and hobbies Home Protector wont cover cover and Home Protector can’t cover semi-professional or professional sports.
Matthew Dobbs, one of the founders of VetYou (pictured), said: “As practising vets, we know the pain of trying to cover rent and mortgage payments when we are unable to work.
"But as busy professionals we often don’t find the time to get the cover we need.
"So we worked with Future Proof to bring this exclusive product to the profession."
https://vetyou.co.uk/home-mortgage/home-protector